Tricuspid Valve Regurgitation Clinical Trials

8 recruiting

Tricuspid Valve Regurgitation Trials at a Glance

11 actively recruiting trials for tricuspid valve regurgitation are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Guangzhou, Wuhan, and Atlanta. Lead sponsors running tricuspid valve regurgitation studies include TRiCares, Deutsches Herzzentrum Muenchen, and Changhai Hospital.

Browse tricuspid valve regurgitation trials by phase

Treatments under study

About Tricuspid Valve Regurgitation Clinical Trials

Looking for clinical trials for Tricuspid Valve Regurgitation? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tricuspid Valve Regurgitation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tricuspid Valve Regurgitation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

The TRICURE EFS Study

Cardiovascular DiseasesTricuspid Valve RegurgitationHeart Valve Diseases
TRiCares15 enrolled9 locationsNCT06506942
Recruiting
Not Applicable

The TRICURE EU Pivotal Study

Cardiovascular DiseasesHeart Valve DiseaseTricuspid Valve Regurgitation
TRiCares80 enrolled8 locationsNCT06581471
Recruiting

Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion

Tricuspid Valve RegurgitationLeft Bundle Branch Area PacingPacemaker+1 more
Hazem Omran200 enrolled1 locationNCT07342036
Recruiting

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

Aortic Valve DiseaseHeart Valve DiseaseTricuspid Valve Regurgitation+11 more
Second Affiliated Hospital, School of Medicine, Zhejiang University10,000 enrolled15 locationsNCT07267117
Recruiting
Not Applicable

Clinical Study of the inQB8 TTVR System

Tricuspid Valve Regurgitation
inQB8 Medical Technologies, LLC50 enrolled6 locationsNCT06611579
Recruiting

Cardiac Implantable Electronic Device- Induced Remodelling of Tricuspid Valve and Right Chambers

Cardiac Pacing, ArtificialTricuspid Valve Regurgitation, Non-rheumatic
Istituto Auxologico Italiano350 enrolled1 locationNCT06914570
Recruiting

Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation

Severe Tricuspid Valve Regurgitation
Azienda Ospedaliero, Universitaria Pisana100 enrolled1 locationNCT05820516
Recruiting

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

Cardiovascular DiseasesTricuspid Valve RegurgitationHeart Valve Diseases
Edwards Lifesciences500 enrolled2 locationsNCT06569602
Recruiting

Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

Tricuspid Valve Regurgitation; Complications, Longterm Outcome
Guangdong Provincial People's Hospital375 enrolled1 locationNCT06554119
Recruiting
Not Applicable

THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein

Tricuspid Valve Regurgitation
Changhai Hospital150 enrolled9 locationsNCT05194423
Recruiting

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

Tricuspid Valve RegurgitationMitral Valve RegurgitationMitral Valve Stenosis
Deutsches Herzzentrum Muenchen5,000 enrolled1 locationNCT04577248